From: O415 Efficacy and safety of 48-week maintenance with QD ATV vs ATV/r (both + 2NRTIs) in patients with VL <50 c/mL after induction with ATV/r + 2NRTIs: study AI424136
Proportion of pts with HIV RNA <50/400 c/mL through Wk 48 of MP (ITT)
ATV/r (N = 85)
ATV (N = 87)
Difference Estimate (95%CI) (ATV – ATV/r)
% <50 c/mL
75
78
2.9 (69.8, 15.5)
% <400 c/mL
81
86